期刊文献+

关于高龄原发输尿管癌手术方式的探讨 被引量:1

Investigation of the Choice between Surgical-treatment of Primary Ureteral Cancer in Eldly Patiants
下载PDF
导出
摘要 目的:探讨高龄原发性输尿管癌患者手术方式的潜在生命风险及其预后。方法:回顾性分析我院自1996年~2010年77例70~89岁高龄原发输尿管癌患者的相关资料,其中42例接受保留肾脏的局部肿瘤切除术(A组),35例接受标准根治术(B组),并对两种术式进行比较。结果:77例术后病理诊断为原发输尿管癌,根治术患者手术时间平均为2小时20分钟,术后并发心衰、肺部感染、肺栓塞5例,围手术期死亡2例。保肾局部肿瘤切除术平均手术时间为1小时15分,术后除一例发生肺部感染外,无其它并发症和围手术期死亡病例。随访6~61个月复发13例,其中局部切除术后复发7例,根治术后复发6例。结论:高龄输尿管癌患者行标准根治手术在围手术期出现并发症或死亡明显高于保肾局部手术患者。故对高龄输尿管癌合并症较多的患者选择保肾局部肿瘤切除术不失为安全有效的方法,且肿瘤复发率与标准根治手术无显著性差异。 Objective:To evaluate the potential risk and prognosis of surgical-treatment of primary ureteral cancer in eldly patients.Methods:77 patients with upper urinary tract tumors who were treated surgically at our hospital from 1996 to 2010,aged 70 to 89,were retrospectively reviewed.42 were received nephron-sparing surgery(A),35 standard-radical surgery(B) as a comparison group.Results:The pathology-diagnose of all patients was primary ureteral cancer.The mean surgical-time of A was 1 hour and 15 minute,with a pneumonia but no other syndrome and death.however,the mean time of B was 2 hour and 20 minute,with 5 heart failure,pneumonia and pulmonary embolism,2 death.The time of following-time was 6-61 month,associating with 13 recrudescence,A(7),B(6).Conclusion:The pattern of surgery for primary ureteral cancer in old patients is not significant.In our study,the outcome of nephron-sparing surgery is slightly better than nephrour-eterectomy surgery,notability improve the current quality of life,and reduce the time of postoperative recuperation.
作者 钟伟 武程
出处 《中国医药导刊》 2012年第8期1326-1327,1329,共3页 Chinese Journal of Medicinal Guide
关键词 原发输尿管肿瘤 手术治疗 预后 Primary ureteral cancer Surgery Prognosis
  • 相关文献

参考文献19

  • 1成波,韩瑞发.影响肾盂输尿管癌预后的多因素分析[J].中华泌尿外科杂志,2008,29(9):631-634. 被引量:8
  • 2Ni(t)(a)G,Georgescu D,Mul escu R,et al.Prognostic factors in laser treatment of upper urinary tract urothelial tumours.J Med Life.2012 Feb 22;5(1):33~8.
  • 3Xu AD,Ng CS,Kamat A,Grossman HB,Dinney C,Sandler CM.Significance of upper urinary tract urothelial thickening and filling defect seen on MDCT urography in patients with a history of urothelial neoplasms.AJR Am J Roentgenol.2010 Oct;195(4):959~65.
  • 4Messer J,Lin YK,Raman JD.The role of lymphadenectomy for upper tract urothelial carcinoma.Nat Rev Urol.2011 May 24;8(7):394~401.
  • 5Munoz JJ,Ellison LM.Upper tract urothelial neoplasms:incidence and survival during the last 2 decades[J].J Urol,2000; 164(5):1523~1525.
  • 6Oosterlinck W,Solsona E,Vander Meijden AP,et al EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma Eur Urol,2004;46(2):147~154.
  • 7O'Brien T,Ray E,Singh R,et al.Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma:a prospective,multicentre,randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial).Eur Urol.2011Oct;60(4):703~10.
  • 8Ouzzane A,Ghoneim TP,Udo K,et al.Small cell carcinoma of the upper urinary tract (UUT-SCC):report of a rare entity and systematic review of the literature.Cancer Treat Rev.2011 Aug;37(5):366~72.
  • 9Cukuranovic R,Ignjatovic I,Visnjic M,et al.Characteristics of upper urothelial carcinoma in an area of Balkan endemic nephropathy in south Serbia.A fifty-year retrospective study.Tumori.2010 Sep-Oct;96(5):674~9.
  • 10刘建业,秦自科,韩辉,刘卓炜,李永红,尧凯,董培,卢可士,许镇州,张志凌,周芳坚.输尿管部分切除术治疗原发性输尿管癌临床疗效分析(附14例报告)[J].临床泌尿外科杂志,2011,26(10):750-751. 被引量:6

二级参考文献22

  • 1Iborra I, Solsona E, Casanova J, et al. Conservative elective treatment of upper urinary tract tumors: a multivariate analysis of prognostic factors for recurrence and progression. J Urol, 2003, 169:82- 85.
  • 2Brown GA, Busby JE, Wood CG, et al. Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm? BJU Int, 2006, 98 : 1176-1180.
  • 3Keeley FX Jr, Bibbo M, Bagley DH. Ureteroscopic treat ment and surveillance of upper urinary tract transitional cell carcinoma. J Urol, 1997, 157:1560-1565.
  • 4Hall MC, Womack S, Sagalowsky AI, et al. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology, 1998, 52:594-601.
  • 5Munoz JJ, Ellison LM. Upper tract urothelial neoplasms:incidence and survival during the last 2 decades. J Urol, 2000, 164:1523 -1525.
  • 6Mohammadzadeh Rezaee M. Endoscopic resection of lower ureter in upper urinary tract tumors. Urol J, 2004, 1:208 -210.
  • 7Chen GL, Bagley DH. Ureteroscopic management of apper tract transitional cell carcinoma in patients with normal contralateral kidneys. J Urol, 2000, 164 : 1173-1176.
  • 8Hisataki T, Miyao N, Masumori N, et al. Risk factors for the development of bladder cancer after upper tract urothelial cancer. Urology, 2000, 55 : 663- 667.
  • 9Hafner C, Knueehel R, Stoehr R, et al. Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic stu- dies. Int J Cancer, 2002, 101:1- 6.
  • 10Takahashi T, Habuchi T, Kakehi Y, et al. Clonal and chronological genetic analysis of multifocal cancers of the bladder and upper urinary tract. Cancer Res, 1998, 58:5835- 5841.

共引文献16

同被引文献13

  • 1Colin P, Ouzzane A, Pignot G, et al. Comparison oI ontological outcomes after segmental uretereetomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results {rom a large French multicentre study[J]. BJLT Int, 2012, 110(8): 1134- 1141.
  • 2Roupr6t M, Babjuk M, Comp6rat E, et al. European guidelines on upper tract urothelial carcinomas: 2013 update[J]. Eur Urol, 2013, 63(6): 1059-1071.
  • 3Montie J E, Clark P E, Eisenberger M A, et al. Blad- der Cancer[J]. J Natl Compr Canc Netw, 2009, 7(1): 8-39.
  • 4Rai B P, Shelley M, Coles B, et al. Surgical manage- ment for upper urinary tract transitional cell carcinoma (UUT-TCC) : a systematic review[J]. BJU Int, 2012, 110(10) : 1426-1435.
  • 5Ho K L, Chow G K. Ureteroscopic resection of upper- tract transitional cell carcinoma[J]. J Endourol, 2005, 19(7) : 841-848.
  • 6Box G N, Lehman D S, Landman J, et al. Minimally invasive management of upper tract malignancies: renal cell and transitional cell carcinoma[J]. Urol Clin North Am, 2008, 35(3): 365-383.
  • 7Cutress M L, Stewart G D, Wells Cole S, et al. Long- term endoscopic management of upper tract urothelial carcinoma= 20-year single-center experienee [J]. BJU Int, 2012, 110(11)= 1608-1617.
  • 8Park B H, Jeon S S. Endoscopic management of upper urinary tract urothelial carcinoma [J] Korean J Urol, 2013, 54 (7): 426 432.
  • 9Simforoosh N, Mosapour E, Maghsudi R. Laparoscop- ic ureteral resection and anastomosis for management of low-grade transitional-cell carcinoma[J]. J Endourol, 2005, 19 (3)= 287-289.
  • 10Rouprfet M, Harmon J D, Sanderson K M, et al. Lap- aroscopic distal ureterectomy and anastomosis for man agement of low-risk upper urinary tract transitional cell carcinoma: preliminary results[J]. BJU Int, 2007, 99 (3): 623-627.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部